-- Researchers at UW-Madison are creating a data tool to improve COVID-19 vaccine access, with a goal of surmounting economic and social health disparities. A release from the university shows that federal officials have relied on mathematical modeling to make decisions on vaccine allocation. But researchers...
A team of researchers led by the University of Wisconsin School of Medicine and Public Health was awarded a four-year, $4 million grant by the National Football League to study the prevention and treatment of hamstring injuries for elite football players. Hamstring injuries are the...
-- A Madison-based startup called Archeus Technologies is gearing up to apply for FDA approval to begin human trials on a new targeting agent used in cancer therapy. This cancer-targeting agent is being used by researchers at UW-Madison and the University of Pittsburgh School of Medicine,...
More doesn’t necessarily mean better — including in cancer treatment. University of Wisconsin–Madison and University of Pittsburgh School of Medicine scientists report today in the journal Science Translational Medicine that combining targeted radiopharmaceutical therapy with immunotherapy significantly boosts eradication of metastatic cancer in mice, even when...